Anaesthesia for ambulatory colonoscopy in adults aims for rapid recovery of cognitive function and a prompt return to a "home-readiness" state. The anaesthetic technique has traditionally included a combination of an opioid and a benzodiazepine 1 . With the advent of propofol, the combination of intravenous fentanyl, midazolam and propofol is commonly used. A recent report suggests that even modest doses of these drugs, in combination, may be associated with prolonged impairment of cognitive function 2 . Sevoflurane has properties which appear desirable in the ambulatory setting. Its relatively low blood/gas partition coefficient 3 provides for both rapid induction and emergence. In addition, its lack of pungency makes it suitable for inhalational induction. Nitrous oxide (N 2 O) was used previously as the sole anaesthetic for colonoscopy and it was found to produce short-lived cognitive impairment 4, 5 . In this study we have compared the recovery parameters in two groups of ambulatory colonoscopy patients. One group received an inhalational anaesthetic with sevoflurane/N 2 O and the other an intravenous fentanyl/midazolam/propofol combination. We studied the immediate emergence parameters and the time-course of recovery of psychomotor function, which relate to patient "home-readiness", "street-fitness" and driving ability.
MATERIALS AND METHODS
Following Day-Surgery Unit Ethics Committee approval and patient consent, 69 ASA 1 and 2 patients, aged from 16 to 80 years scheduled for elective colonoscopy at a private Day-Surgery Unit were enrolled into this prospective, randomized, singleblinded study. Exclusion criteria included patients on psychoactive medication, drug or alcohol dependence, pregnancy, a history of renal or hepatic disease, language limitation or cognitive impairment suggesting inability to comply with the study protocol and patients with a mask aversion and any other contraindication to facemask anaesthesia. Thirty-five patients received fentanyl, midazolam and propofol (FMP group), 34 received sevoflurane and nitrous oxide (sevo/N 2 O group).
Patients abstained from stimulant or depressant beverages or substances from 1700 hours on the day prior to the procedure. They received sodium picophosphate or polyethylene glycol (GlycoprepPharmatel Pty Ltd, Thornleigh, N.S.W.) for bowel preparation, at the discretion of their gastroenterologist.
After arrival and routine day-surgery admission procedures, patients undertook a 45 minute practice session of all psychomotor assessment measures. This aimed to reduce anxiety about testing and minimize the "learning effect" during the study. Then, baseline scores were recorded. The psychomotor test battery comprised of nine tests:
• four reaction time tests: Simple reaction time (SRT), choice reaction time (CRT), sequential reaction time 1 (SRT 1), sequential reaction time 2 (SRT 2) • two short term memory tests: Immediate, delayed picture recall
A brief description of these tests is provided in the Appendix. SRT and CRT have been used extensively in studies of recovery after anaesthesia 6 . SRT 1 and SRT 2 were added to increase sensitivity as they represent more complex tasks than the SRT and CRT. Memory testing by picture recall tasks was noted previously to be the most sensitive measure of residual drug effect 7 . The DSST provides a general measure of psychomotor performance 2 . It has shown sensitivity to opioids 6 , propofol 6 , benzodiazepines 8 , sevoflurane 9 and nitrous oxide 9 . The GP was offered as a test for motor skills and it has been found sensitive to impairment after general anaesthesia and sedation 6 . The SCT was included as it has been found sensitive to mild cognitive impairment in other settings 10 . The entire test battery took 15 minutes. Testing was done at baseline and at 30, 60, 90 and 120 minutes after patient admission to the recovery ward, supervised by a "blinded" clinical psychologist. At these times patients also provided a subjective assessment of their mood by scoring on eight 100 mm visual analog scales (VAS) the following adjectives: sedation, physical relaxation, nausea, anxiety, alertness, motivation, coordination and a general feeling of "well-being". Estimates could range from none to extreme.
Following recording of baseline scores and admission to the endoscopy theatre, patients were randomly allocated into a total intravenous or inhalational anaesthesia group, by a computer-generated random numbers table. After application of electrocardiogram, pulse oximeter probe and automated blood pressure cuff, an intravenous cannula was inserted and patients were placed in the left lateral position for the procedure. A screen was erected across the anaesthetic field to 'blind" the gastroenterologist to the anaesthetic protocols. Preoxygenation was provided with a circle circuit at a fresh gas flow of 9 litres/min for 60 seconds, by a transparent, close-fitting facemask. Patients randomized to intravenous anaesthesia (FMP group) received fentanyl 1 µg/kg and midazolam 0.05 mg/kg by a non-blinded anaesthetist. A further midazolam bolus of 0.025 mg/kg was administered two minutes later at the discretion of the anaesthetist, depending on the sedation level achieved by the initial doses. The aim was to have patients deeply sedated during the procedure, with lack of response to verbal commands and no movement or verbal expressions of discomfort, while independently maintaining spontaneous respiration through a patent airway. Propofol boluses of 10 to 20 mg were given, as needed, just prior to and during the procedure to meet these endpoints. The inhalational anaesthesia group patients (sevo/N 2 O group) received 5 ml of intravenous normal saline followed by an inhalational induction with sevoflurane 8% (delivered by a Penlon Sigma Elite vaporizer, Penlon Ltd, Abingdon, Oxon, U.K.) and N 2 O 67% in oxygen (at 9 litres/min) until loss of eyelid reflex. The anaesthetist then titrated sevoflurane 1 to 2% with N 2 O 67% in oxygen (at 3 litres/min) to meet the same endpoints as above. The facemask remained in situ for patients in both groups until completion of the procedure. Intravenous fluids were administered at the discretion of the anaesthetist. It was our aim to maintain haemodynamic parameters within 20% of baseline. All anaesthetics were administered by the same non-blinded anaesthetist and all procedures were performed by the same gastroenterologist. Total doses of intravenous drugs, time to intubation of the caecum, total procedure duration and type of procedures performed in association with colonoscopy (if any), were noted. At the end of the procedure the gastroenterologist appraised the conditions for performing colonoscopy as very good, good, average, poor or very poor, based on his perception of movement or verbal expression of discomfort by the patient during the case. After completion, a Hudson mask was placed on the patient's face and oxygen at 6 litres/min was administered during transfer to the recovery ward, situated adjacent to the theatre. There, a "blinded" nurse observer recorded immediate recovery times. The times at which patients were able to open their eyes and squeeze the assessor's hand on command (time to obeying commands) and recall their name and date of birth (time to orientation) were assessed every 15 seconds and recorded. Times to sitting up in bed unaided and standing up steadily (as determined by Romberg's test 11 ), were assessed every five minutes from the time the patients achieved orientation and were also recorded. An assessment of sedation was performed at five-minute intervals for 30 minutes after patient arrival in recovery, as previously described 8 ( Table 1) .
Patients in both groups remained in the daysurgery unit until after the last occasion of testing on the psychomotor tasks and completion of the VAS, 120 minutes after the end of the procedure. During that time patients were allowed to have clear fluids and a light meal but no caffeine-containing beverages.
On completion of testing, patients were asked to rate their approval of their anaesthetic and about recall of events during the procedure. They were then discharged if they satisfied the unit's usual discharge criteria.
The required sample size was derived from a power analysis using a "two means" formula 12 , for a power level of 0.80 and a significance level of 0.05, based on patient psychomotor performance after a sevoflurane/N 2 O anaesthetic previously published 13 (data obtained by personal communication).
Unless otherwise stated the data is reported as mean values, with variability expressed as standard deviation (SD). The Mann Witney U test or the twosample t test were used to compare the patient demographics, baseline psychomotor scores and the immediate recovery data depending on whether the variables were categorical or continuous. For each psychomotor test and VAS, the Wilcoxon's signed rank test was used to test whether a significant change from baseline had occurred within each study group at each time point. The Mann-Witney U test was then used to assess if the "within group" changes from baseline at each time point were comparable in the two groups. Statistical significance was assigned at P<0.05.
RESULTS
Data from 69 patients were analysed; 35 patients received FMP; 34 patients received sevo/N 2 O. The two study groups were comparable with respect to demographics, type of bowel preparation, time to caecal intubation and total procedure duration ( Table  2 ). The types of procedures performed are listed in Table 3 . The average drug doses used in the FMP group were: fentanyl 75 µg, midazolam 5.2 mg and propofol 48 mg. The gastroenterologist's appraisal of the anaesthetic technique is shown in Table 4 . A greater percentage of patients in the sevo/N 2 O group were placed into the very good category, compared to FMP (P 0.002).
Immediate recovery data demonstrated a more rapid emergence in the FMP group (Table 5) (Figure 2 ). The sevo/N 2 O group times did not differ from baseline on any of the testing occasions. In contrast the FMP group times were prolonged at the 30 minute testing, on all reaction time tasks, compared to baseline. Intergroup comparison at 30 minutes showed the FMP group times to be more prolonged on the CRT and SRT 1 tasks. Beyond the 30 minute testing session, the performance of the FMP group did not differ from baseline or the other group.
Performance on the picture recall task appeared to be more sensitive for both anaesthetic techniques (Figure 3) . In both the immediate and delayed recall tasks the performance of both groups was impaired compared to baseline at all testing sessions. The single intergroup difference was noted at the 30 minute session, where the deterioration in performance was greater in the FMP group in both the immediate and delayed recall tasks.
Performance on the DSST, GP and SCT is shown in Figure 4 . The sevo/N 2 O group performed worse than baseline only at the 30 minute testing session, on the DSST and the GP. No impairment was evident on the SCT where performance was better than baseline both at 60 and 120 minutes. In contrast, the FMP group's performance was impaired at 30 and 60 minutes on the DSST, 30 and 90 minutes minutes on the SCT and 30, 60 and 90 minutes on the GP, both in reference to baseline and the other group's performance.
Very few intergroup differences were detected on the VAS (Figures 5, 6 ). On the VAS for sedation the FMP group reported increased sedation compared to baseline, at 30 and 60 minutes while the sevo/N 2 O group reported increased sedation only at 30 minutes. At 90 minutes the FMP group's sedation score was higher than the other group. The FMP group also reported decreased alertness and motivation at 30 minutes, compared to the sevo/N 2 O group. The co-ordination score of the FMP group was also decreased at 30 minutes, but only compared to baseline. There were no intergroup differences on the VAS for nausea, anxiety and "well-being".
There was no difference in the patient appraisal of the anaesthetic technique ( group had some recollection of events during the procedure. No further details were provided by these patients. All patients were discharged home following completion of the 120 minute testing session.
DISCUSSION
In this study we aimed to provide deep sedation/general anaesthesia for patients having colonoscopy. Many other techniques have been used 14 . Some authors suggest that the procedure can be performed without sedation in the majority of patients 15, 16 . Examination of their data shows dissatisfaction in a small but significant proportion of their patients. Many factors can influence the degree of discomfort experienced during colonoscopy, including patient expectations and culture, gender (greater pain scores reported in women) and the endoscopist's experience 17, 18 . Faced with unpredictability, many endoscopists routinely administer intravenous conscious sedation. Despite this, pain scores may still be significant and a 15% patient dissatisfaction rate has been reported 19 . When compared with conventional intravenous conscious sedation, inhalational sedation with N 2 O has been shown to result in earlier home discharge and faster recovery of psychomotor function, after colonoscopy 4, 5, 20 . However, procedure tolerance is not improved. Use of deep sedation or general anaesthesia appears well accepted for paediatric colonoscopy 21, 22 . It is our impression that this practice is also very common when anaesthetists provide care for adult colonoscopy patients, to enable optimal conditions for the procedure and eliminate pain and dissatisfaction. Published data suggests that 50 to 60% of all the morbidity/mortality occurring during endoscopic procedures is directly related to the administration of sedative and opioid drugs 23 . It has also been suggested that anaesthesia increases the risk of colonic perforation 14 . Our results show a faster emergence of the FMP group patients by 2.2 minutes ( Table 5 ). The remaining immediate recovery variables were comparable in the two groups with patients able to sit up unaided and stand steadily, within 16 and 28 minutes, respectively. There are no previous reports of emergence times after a fentanyl, midazolam and propofol combination, as used here, for comparison. When a sevoflurane/N 2 O anaesthetic was used for induction/maintenance of anaesthesia for brief surgical procedures, the times to eye-opening, orientation, sitting-up and standing up were 5, 5, 19 and 31 minutes, respectively 24 . Our sevo/N 2 O group times are similar. In other reports, longer anaesthesia times and co-administration of other sedative drugs resulted in longer emergence times 13, 25 . The faster emergence of the FMP group patients may relate to a difference in anaesthetic depth during the procedure. There is no defined "MACequivalent" for intravenous anaesthetics and the clinical signs against which the anaesthetic drugs were titrated are notoriously unreliable as indices of depth 26 . The way in which the drugs were administered may have prejudiced towards a "lighter" anaesthesia plane in the FMP group patients. While the administration of the inhalational drugs persisted until the end of the procedure, in the FMP group propofol boluses were only given if there were signs of inadequate anaesthesia, most commonly patient movement. It is known that very little discomfort is experienced during the withdrawal phase of the procedure 27 . It is likely that the last propofol dose was given some minutes prior to the end of the procedure. A greater anaesthetic depth in the inhalational group may have also been responsible for the gastroenterologist's appraisal indicating improved conditions in this group of patients (Table 4) .
Observer sedation scores had returned to baseline by 30 minutes after the end of the procedure in both groups (Figure 1 ). With the exception of differences in motivation and alertness scores at 30 minutes and sedation scores at 90 minutes (all in favour of the sevo/N 2 O group), subjective reporting on the VAS did not differentiate between the two anaesthetic techniques (Figures 5, 6) .
Results of psychomotor testing show that, with the exception of performance on picture recall, cognitive impairment was short-lived in the sevo/N 2 O group of patients. Deterioration of performance, compared to baseline, was only evident at the 30 minute testing session on the DSST and the GP. No impairment was evident on reaction times or the SCT. On the latter, improved performance at 60 and 120 minutes (as evidenced by a shorter time to completion of the task- Figure 4) suggests a learning effect. The FMP group's performance was impaired at 30 minutes on reaction times, 30 and 60 minutes on the DSST, 30 and 90 minutes on the SCT, and 30, 60 and 90 minutes on the GP both in reference to baseline and the other group's performance. We conclude that with the exception of picture recall, psychomotor impairment was greater and more prolonged by 30 to 90 minutes in the FMP group patients. Performance on the picture recall task appeared the most sensitive to anaesthesia drug effects, with both groups performing worse than baseline for the duration of testing. This finding is in agreement with a previous report 7 . However our findings on this test may partly reflect increasing task difficulty with repeated testing as we observed an increasing trend for patients to recall pictures presented in previous sessions. This is not stated to dispute the presence of memory impairment after anaesthesia, which has been documented previously 7, 28 , but to raise caution when interpreting the results of repeated measures of memory.
The psychomotor effects of the drugs used in this study have been previously assessed. In a healthy volunteer study, FMP (fentanyl 50 µg, midazolam 2 mg and propofol 35 mg, per 70 kg body weight) induced impairment on a DSST, which, at 75 minutes after drug administration, was comparable to that caused by a blood alcohol concentration of 0.11% (greater than twice the legal limit for driving in Australia) 2 . No impairment was detected at 180 minutes after drug dosing. Their subjects were younger and drug doses were lower than the ones we used. The midazolam component of the FMP combination appears the key drug producing prolonged psychomotor impairment 2, 29 . The psychomotor effects of N 2 O appear to closely correlate with its kinetics 5, 9, 30 . In two separate studies involving healthy volunteers, after inhalation of 30% N 2 O for 35 and 40 minutes, psychomotor performance had returned to baseline by 5 and 22 minutes respectively 9, 30 . In another report, after self-administration of 50% N 2 O by patients having colonoscopy, psychomotor performance had returned to baseline by 30 minutes following the end of the procedure 5 . Psychomotor performance, assessed on a DSST, after inhalation of a sevoflurane sub-anaesthetic concentration of 0.6% for 35 minutes by volunteers was shown to be impaired at 5 but not at 30 minutes after the end of administration 9 . Our results are in accord with these findings.
Psychomotor testing was included in our protocol because it is thought to provide a more sensitive index of patient recovery compared to clinical assessment 5 . It is assumed that test performance equates to an aptitude for real-life skills 7 . Some interpretation is required to link our findings with potential clinical significance.
In a busy ambulatory endoscopy setting, fast emergence facilitates the "turn-over" of patients and may also enhance patient safety. Both groups demonstrated rapid emergence. Our study protocol did not allow comparison of times to home discharge, as all patients needed to remain in the unit until after completion of the 120 minute testing. Subsequently, all satisfied the unit's usual criteria and were discharged home. The time to home discharge (intermediate recovery time) may be influenced by the type of anaesthetic used and this time may significantly affect the cost of hospitalization 31 . While the role of psychomotor testing is not to routinely determine when patients can go home, if a new anaesthetic technique is found to result in earlier recovery of psychomotor function then it is a fair assumption that higher intellectual function may return earlier as well 6 . The ambulatory unit may then be in a position to reconsider its guidelines for discharge to take advantage of the faster recovery. It has been noted previously that the current discharge criteria may lack the sensitivity to take advantage of improvements in recovery with the newer, less soluble inhaled anaesthetics 32 . It remains to be seen whether use of sevoflurane and N 2 O for colonoscopy patients will result in earlier home discharge.
"Street-fitness" is an ill-defined concept suggesting that the patient has recovered enough to be able to cross roads and use public transport and is therefore able to be discharged without an escort 6 . The ability to drive or use heavy machinery defines the next level of recovery. Although specific psychomotor tests have been suggested as valid in testing for these late levels of recovery 33 , researchers are often hesitant about making definitive statements about these on the basis of such testing alone. Reasons for this include the significant medico-legal implications, concerns about test sensitivity and specificity and the learning effect during testing. Lack of impairment on testing may not equal complete recovery. Another important point is that the essential feature of a "street-fit" person and safe driving is the ability to make sound decisions about everyday events under everyday circumstances 6 . Decision-making is not one of the functions we tested, and the relationship between psychomotor testing and decision-making is not clear 6 . Despite this, earlier reports suggest that tests such as the simple reaction time is a sensitive analog of car driving 7 and that results of choice reaction time and co-ordination tests correlate with real behaviour in traffic 34 . While there is no clear relationship between postoperative psychomotor scores and the ability to perform daily tasks, the earlier recovery of basic psychomotor skills in our inhalational group patients, as shown by a comprehensive battery of tests, would suggest that "street-fitness" and driving ability may also return earlier in these patients. However, the persistence of memory impairment for the duration of testing in both groups of patients is of concern and it has significant medico-legal implications. We recommend that day patients should be escorted home after either anaesthesia technique. Our data does not permit us to make definitive statements about exact times to street-fitness or driving ability. The use of alcohol-induced psychomotor impairment as a reference for anaesthetic drug-induced effects 2, 29 may be relevant in more accurately addressing these important clinical issues.
Our study can be criticized in that the anaesthetist was aware of the anaesthetic drugs being administered and bias cannot be excluded. While an attempt was made to "blind" the patients by having all receive both an intravenous injection and inhalation of a gas, successful patient blinding cannot be assumed due to the characteristic colour of propofol (which was not concealed), and the odour of sevoflurane. However the recovery endpoints were assessed by blinded observers. The absence of a control group made it impossible to establish if pre-training on the psychomotor tests was adequate to prevent learning during the study. This study can be further criticized in that it was not possible to ensure that patients in both groups were at the same anaesthetic depth during the procedure. This may have influenced the recovery variables, as discussed above. However our study was designed to mimic the clinical situation, where the anaesthetics were titrated to maintain an adequate depth of anaesthesia appropriate for patient comfort and the conduct of the procedure.
We conclude that a sevoflurane/N 2 O anaesthetic has a suitable recovery profile for ambulatory colonoscopy and permits an earlier recovery of cognitive function than a combination of intravenous fentanyl, midazolam and titrated propofol. The clinical significance of this in terms of times to hospital discharge, "street-fitness" and driving requires further clarification.
